Healthcare provider profile · identity verified

John Anthony Lafata, DO

Allopathic & Osteopathic Physicians|Internal Medicine · CLYDE, NC · NPI 1083686646

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show John Anthony Lafata, DO received $90.88 in general payments during 2025 across 4 reported records.

PFIZER INC. accounted for 78.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Abrysvo by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 778 claims for Eliquis by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Paxlovid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$90.88

4 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
PFIZER INC.	Unresolved — no canonical attribution shown	$70.97	78.1%	3	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$19.91	21.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$90.88	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
ELIQUIS Normalized: eliquis	Drug	PFIZER INC.	$70.97	3	2025
Source payment records 2025-02-13 · PFIZER INC. · $21.12 · Open Payments source 2025-05-14 · PFIZER INC. · $24.67 · Open Payments source 2025-07-09 · PFIZER INC. · $25.18 · Open Payments source
NURTEC ODT Normalized: nurtec odt	Drug	PFIZER INC.	$70.97	3	2025
Source payment records 2025-02-13 · PFIZER INC. · $21.12 · Open Payments source 2025-05-14 · PFIZER INC. · $24.67 · Open Payments source 2025-07-09 · PFIZER INC. · $25.18 · Open Payments source
EVENITY Normalized: evenity	Biological	Amgen Inc.	$19.91	1	2025
Source payment records 2025-11-12 · Amgen Inc. · $19.91 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
ELIQUIS eliquis	2025	Eliquis	2024	778	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ABRYSVO open payments reported associated product	CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147	Abrysvo · 2024 Exact normalized brand match · 1 Part D row	28	28
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	778	106
PFIZER INC. Exact reporting entity; no affiliate inference	2025	PAXLOVID open payments reported associated product	CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432	Paxlovid · 2024 Exact normalized brand match · 1 Part D row	28	28

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	1071	230
Atorvastatin Calcium	Atorvastatin Calcium	862	196
Amlodipine Besylate	Amlodipine Besylate	851	220
Lisinopril	Lisinopril	848	197
Potassium Chloride	Potassium Chloride	804	164
Eliquis	Apixaban	778	106
Trazodone Hcl	Trazodone Hcl	701	152
Omeprazole	Omeprazole	690	179
Gabapentin	Gabapentin	671	158
Losartan Potassium	Losartan Potassium	589	149
Furosemide	Furosemide	573	142
Metoprolol Succinate	Metoprolol Succinate	505	126
Rosuvastatin Calcium	Rosuvastatin Calcium	490	131
Escitalopram Oxalate	Escitalopram Oxalate	457	112
Pantoprazole Sodium	Pantoprazole Sodium	444	105
Pravastatin Sodium	Pravastatin Sodium	439	97
Sertraline Hcl	Sertraline Hcl	399	107
Metformin Hcl	Metformin Hcl	384	96
Carvedilol	Carvedilol	364	98
Tamsulosin Hcl	Tamsulosin Hcl	360	82
Metoprolol Tartrate	Metoprolol Tartrate	358	91
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	327	68
Tramadol Hcl	Tramadol Hcl	326	83
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	302	48
Spironolactone	Spironolactone	298	70
Alprazolam	Alprazolam	293	51
Simvastatin	Simvastatin	285	68
Albuterol Sulfate Hfa	Albuterol Sulfate	268	89
Mirtazapine	Mirtazapine	267	67
Lorazepam	Lorazepam	264	68
Duloxetine Hcl	Duloxetine Hcl	248	61
Famotidine	Famotidine	239	55
Montelukast Sodium	Montelukast Sodium	219	54
Metformin Hcl Er	Metformin Hcl	213	56
Donepezil Hcl	Donepezil Hcl	211	49
Clopidogrel	Clopidogrel Bisulfate	209	53
Fluticasone Propionate	Fluticasone Propionate	199	70
Hydrochlorothiazide	Hydrochlorothiazide	197	54
Prednisone	Prednisone	195	98
Glimepiride	Glimepiride	186	48
Ropinirole Hcl	Ropinirole Hcl	185	35
Allopurinol	Allopurinol	182	50
Ozempic	Semaglutide	166	32
Chlorthalidone	Chlorthalidone	165	46
Irbesartan	Irbesartan	160	46
Cephalexin	Cephalexin	157	100
Doxycycline Hyclate	Doxycycline Hyclate	157	103
Atenolol	Atenolol	154	36
Tizanidine Hcl	Tizanidine Hcl	153	32
Jardiance	Empagliflozin	150	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	145	36
Citalopram Hbr	Citalopram Hydrobromide	144	34
Buspirone Hcl	Buspirone Hcl	143	33
Xarelto	Rivaroxaban	141	24
Meloxicam	Meloxicam	137	39
Ondansetron Hcl	Ondansetron Hcl	132	49
Quetiapine Fumarate	Quetiapine Fumarate	131	26
Memantine Hcl	Memantine Hcl	124	30
Oxycodone Hcl	Oxycodone Hcl	124	39
Nystatin	Nystatin	120	54
Hydralazine Hcl	Hydralazine Hcl	119	33
Clonazepam	Clonazepam	118	21
Primidone	Primidone	118	26
Arexvy	Rsvpref3 Antigen/As01e/Pf	116	113
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	112	29
Hydroxyzine Hcl	Hydroxyzine Hcl	111	27
Benazepril Hcl	Benazepril Hcl	109	28
Fluoxetine Hcl	Fluoxetine Hcl	109	27
Valsartan	Valsartan	108	29
Mounjaro	Tirzepatide	107	19
Baclofen	Baclofen	106	22
Bumetanide	Bumetanide	105	21
Zolpidem Tartrate	Zolpidem Tartrate	105	27
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	104	27
Carbidopa-Levodopa	Carbidopa/Levodopa	103	15
Myrbetriq	Mirabegron	98	13
Nortriptyline Hcl	Nortriptyline Hcl	92	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	89	22
Finasteride	Finasteride	87	17
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	86	20
Digoxin	Digoxin	85	17
Diazepam	Diazepam	83	19
Estradiol	Estradiol	81	28
Warfarin Sodium	Warfarin Sodium	81	17
Esomeprazole Magnesium	Esomeprazole Magnesium	80	25
Lovastatin	Lovastatin	80	20
Pregabalin	Pregabalin	77	21
Alendronate Sodium	Alendronate Sodium	75	18
Topiramate	Topiramate	74	12
Triamcinolone Acetonide	Triamcinolone Acetonide	73	43
Azithromycin	Azithromycin	71	51
Pioglitazone Hcl	Pioglitazone Hcl	71	14
Janumet	Sitagliptin Phos/Metformin Hcl	70	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	69	47
Latanoprost	Latanoprost	68	13
Venlafaxine Hcl Er	Venlafaxine Hcl	68	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	66	48
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	20
Oxybutynin Chloride Er	Oxybutynin Chloride	66	12
Levetiracetam	Levetiracetam	64	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	63	42
Olanzapine	Olanzapine	63	14
Amitriptyline Hcl	Amitriptyline Hcl	62	15
Entresto	Sacubitril/Valsartan	62	12
Januvia	Sitagliptin Phosphate	62	11
Lamotrigine	Lamotrigine	62	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	62	20
Solifenacin Succinate	Solifenacin Succinate	57	15
Bupropion Hcl Sr	Bupropion Hcl	56	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	23
Fludrocortisone Acetate	Fludrocortisone Acetate	56	14
Verapamil Er	Verapamil Hcl	56	12
Ibandronate Sodium	Ibandronate Sodium	54	20
Indapamide	Indapamide	53	13
Synthroid	Levothyroxine Sodium	53	13
Doxazosin Mesylate	Doxazosin Mesylate	52	12
Nifedipine Er	Nifedipine	52	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	52	12
Ipratropium Bromide	Ipratropium Bromide	51	17
Levofloxacin	Levofloxacin	51	39
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	16
Divalproex Sodium	Divalproex Sodium	50	14
Torsemide	Torsemide	50	12
Ondansetron Odt	Ondansetron	49	26
Trulicity	Dulaglutide	49	13
Fluconazole	Fluconazole	48	31
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	12
Acyclovir	Acyclovir	47	15
Methimazole	Methimazole	46	suppressed
Nitroglycerin	Nitroglycerin	46	26
Nyamyc	Nystatin	46	22
Risperidone	Risperidone	46	suppressed
Ketoconazole	Ketoconazole	45	24
Ramipril	Ramipril	45	suppressed
Ventolin Hfa	Albuterol Sulfate	45	13
Nuplazid	Pimavanserin Tartrate	44	suppressed
Cefuroxime	Cefuroxime Axetil	43	31
Colestipol Hcl	Colestipol Hcl	43	12
Clonidine Hcl	Clonidine Hcl	42	14
Farxiga	Dapagliflozin Propanediol	42	11
Olmesartan Medoxomil	Olmesartan Medoxomil	41	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	40	suppressed
Prazosin Hcl	Prazosin Hcl	40	suppressed
Bupropion Xl	Bupropion Hcl	39	13
Methylprednisolone	Methylprednisolone	38	29
Colchicine	Colchicine	37	12
Combivent Respimat	Ipratropium/Albuterol Sulfate	37	suppressed
Propranolol Hcl	Propranolol Hcl	37	suppressed
Cefdinir	Cefdinir	36	29
Fentanyl	Fentanyl	36	suppressed
Methocarbamol	Methocarbamol	36	13
Creon	Lipase/Protease/Amylase	35	suppressed
Humalog Kwikpen U-100	Insulin Lispro	35	13
Insulin Lispro Kwikpen U-100	Insulin Lispro	35	12
Lansoprazole	Lansoprazole	35	suppressed
Methotrexate	Methotrexate Sodium	35	suppressed
Metronidazole	Metronidazole	35	13
Sucralfate	Sucralfate	35	12
Dexlansoprazole Dr	Dexlansoprazole	34	suppressed
Doxepin Hcl	Doxepin Hcl	34	suppressed
Ibuprofen	Ibuprofen	34	suppressed
Naproxen	Naproxen	34	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Methenamine Hippurate	Methenamine Hippurate	33	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	32	suppressed
Celecoxib	Celecoxib	32	suppressed
Promethazine Hcl	Promethazine Hcl	32	15
Ezetimibe	Ezetimibe	31	suppressed
Memantine Hcl Er	Memantine Hcl	31	suppressed
Rivastigmine	Rivastigmine	31	suppressed
Midodrine Hcl	Midodrine Hcl	30	suppressed
Nebivolol Hcl	Nebivolol Hcl	30	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	29	suppressed
Divalproex Sodium Er	Divalproex Sodium	29	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	29	13
Lidocaine Hcl	Lidocaine Hcl	29	18
Timolol Maleate	Timolol Maleate	29	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	28	28
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	12
Paxlovid	Nirmatrelvir/Ritonavir	28	28
Testosterone Cypionate	Testosterone Cypionate	28	14
Aripiprazole	Aripiprazole	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Hydrocortisone	Hydrocortisone	27	11
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Ceftriaxone	Ceftriaxone Sodium	26	19
Cinacalcet Hcl	Cinacalcet Hcl	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	15
Dropsafe Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Amoxicillin	Amoxicillin	25	19
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	24	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	24	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	17
Novolog Flexpen	Insulin Aspart	23	11
Bydureon Bcise	Exenatide Microspheres	22	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	14
Meclizine Hcl	Meclizine Hcl	21	suppressed
Morphine Sulfate	Morphine Sulfate	21	12
Sotalol	Sotalol Hcl	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Clonidine	Clonidine	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	20	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	14
Temazepam	Temazepam	20	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Lumigan	Bimatoprost	19	suppressed
Metolazone	Metolazone	19	suppressed
Mirabegron Er	Mirabegron	19	suppressed
Novolog	Insulin Aspart	19	suppressed
Varenicline Tartrate	Varenicline Tartrate	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Calcitriol	Calcitriol	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Lactulose	Lactulose	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Lagevrio (Eua)	Molnupiravir	17	17
Nystop	Nystatin	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Ertapenem	Ertapenem Sodium	16	suppressed
Erythromycin	Erythromycin Base	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Linzess	Linaclotide	16	suppressed
Rivastigmine	Rivastigmine Tartrate	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	15	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Cholestyramine Light	Cholestyramine	14	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Ibu	Ibuprofen	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Combigan	Brimonidine Tartrate/Timolol	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Modafinil	Modafinil	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Donepezil Hcl Odt	Donepezil Hcl	11	suppressed
Enulose	Lactulose	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$90.88 · 4 records	PFIZER INC.	ELIQUIS, EVENITY, NURTEC ODT	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Eliquis play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error